PRESS RELEASES More events are coming soon. Keyword Search Year: 202120202019201820172016201520142013 11/29/21 Summary ToggleTRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China Printer Friendly PDF Version 11/11/21 Summary ToggleTRACON Pharmaceuticals to Present at the Jefferies London Virtual Healthcare Conference Printer Friendly PDF Version 11/03/21 Summary ToggleTRACON Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update Printer Friendly PDF Version 10/27/21 Summary ToggleTRACON to Report Third Quarter 2021 Financial Results and Company Highlights on November 3, 2021 Printer Friendly PDF Version 10/13/21 Summary ToggleTRACON Pharmaceuticals Announces Appointment of Carol Lam to its Board of Directors Printer Friendly PDF Version 10/11/21 Summary ToggleTRACON Pharmaceuticals and Eucure Biopharma, a Subsidiary of Biocytogen, Announce Partnership for Development of Clinical Stage CTLA-4 Antibody YH001 Printer Friendly PDF Version 09/13/21 Summary ToggleTRACON Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit Printer Friendly PDF Version 09/07/21 Summary ToggleTRACON Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Printer Friendly PDF Version 09/02/21 Summary ToggleTRACON Pharmaceuticals to Present at the Wells Fargo Virtual Healthcare Conference Printer Friendly PDF Version 08/11/21 Summary ToggleTRACON Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update Printer Friendly PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
